FOLH1 and neoplasm: A molecular analysis of the non-responding tumor tissue with sufficient PSMA expression from seven patients after therapy with 225Ac-labeled PSMA-617 shows a high rate of alterations in the DNA damage-repair or cell cycle checkpoint [103].